[Federal Register Volume 67, Number 86 (Friday, May 3, 2002)]
[Notices]
[Pages 22434-22436]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-10834]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 02089]


Thalassemia Prevention Education and Outreach; Notice of 
Availability of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2002 funds for a cooperative agreement 
program for Thalassemia Prevention Education and Outreach. This program 
addresses the ``Healthy People 2010'' focus area(s) of Disability, 
Secondary Conditions, Education, and Community-Based Programs.
    The purpose of the program is to increase access to prevention 
services for persons with thalassemia by supporting prevention 
education and outreach activities to increase knowledge about proven 
prevention strategies, and encourage adoption of healthy behaviors that 
reduce or prevent

[[Page 22435]]

complications of thalassemia including prevention of blood borne 
infections.

B. Eligible Applicants

    Applications may be submitted by public and private nonprofit 
organizations and by governments and their agencies; that is, 
universities, colleges, research institutions, hospitals, other public 
and private nonprofit organizations, State and local governments or 
their bona fide agents, including the District of Columbia, the 
Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of 
the Northern Mariana Islands, American Samoa, Guam, the Federated 
States of Micronesia, the Republic of the Marshall Islands, and the 
Republic of Palau, federally recognized Indian tribal governments, 
Indian tribes, or Indian tribal organizations and Faith-based 
organizations are eligible for this award.

    Note: Title II of the United States Code section 1611 states 
that an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant or loan.

C. Availability of Funds

    Approximately $150,000 is available in FY 2002 to fund one award. 
It is expected that the award will begin on or about September 1, 2002 
and will be made for a 12-month budget period within a project period 
of up to five years. The funding estimate may change.
    Continuation awards within an approved project period will be on 
the basis of satisfactory progress as evidenced by required reports and 
the availability of funds.

Funding Preference

    Preference will be given to a national nonprofit organization with 
a current working relationship with the thalassemia community including 
local chapters and foundations as well as thalassemia treatment and 
prevention center provider groups in order to enhance the national 
thalassemia prevention program.

D. Program Requirements

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities under 1. 
(Recipient Activities) and CDC will be responsible for the activities 
listed under 2. (CDC Activities).

1. Recipient Activities

    a. Work with locally based thalassemia treatment centers and lay 
organizations to develop and implement outreach goals to increase 
access of healthcare and prevention services to under-served 
populations.
    b. Encourage use of appropriate safety precautions to reduce 
transmission of blood borne infections through the use of blood 
products. Participate in a formalized network of communication with the 
CDC and other Federal agencies when blood safety and availability 
issues arise. Encourage community participation in blood safety 
monitoring efforts.
    c. Provide opportunities for thalassemia treatment center nurse 
coordinators to receive state of the art prevention information and 
training in order to deliver consistent prevention messages to persons 
with thalassemia.
    d. Facilitate provider involvement and collaboration in consumer-
based program activities between the recipient and the thalassemia 
treatment and prevention centers.

2. CDC Activities

    a. Provide scientific and public health information regarding the 
prevention of complications of thalassemia. This includes reviewing 
educational and promotional materials developed by the proposed 
program.
    b. Provide consultation and technical assistance for program 
planning, development, implementation, and evaluation, which may 
include consulting with committees or working groups whose operations 
may impact the proposed programs.
    c. Collaborate in the presentation, publication, and dissemination 
of information resulting from these activities.
    d. Facilitate provider involvement and collaboration in consumer-
based program activities between the recipient and the thalassemia 
treatment and prevention centers.

E. Content

Letter of Intent (LOI)

    An LOI is optional for this program. The narrative should be no 
more than 3 single-spaced pages, printed on one side, with one-inch 
margins, and unreduced font. Your letter of intent will be used to 
enable CDC to plan for the review, and should include the following 
information (1) the Program Announcement Number 02089, (2) name and 
address of institution, (3) name, address, and telephone number of 
contact person. Notification can be provided by facsimile, postal mail, 
or electronic mail (E-mail).

Applications

    Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated on the criteria 
listed, so it is important to follow them in laying out your program 
plan. The narrative should be no more than 25 double-spaced pages, 
printed on one side, with one-inch margins, and unreduced font.
    The application should include:
1. Background and Need
    Describe the need for prevention information, education, and 
outreach programs. Explain the basis for providing such programs, 
expected outcomes and the relevance to preventing complications, and 
promoting healthy behaviors among people with thalassemia.
2. Objectives
    Establish long-range (five year) and short-term (one year) 
objectives for programmatic plans. Objectives should be specific, 
measurable, time-phased and realistic.
3. Operational Plan
    Describe the methods by which the objectives will be achieved, 
including their sequence.
4. Evaluation Plan
    Describe the plans to monitor the progress of the program, and to 
evaluate the outcomes of the proposed activities.
5. Program Management
    Describe the roles and responsibilities of all project staff in the 
proposed project. The description should include their titles, 
qualifications, and experience, as well as the percentage of time each 
will devote to the project, and the portions of their salaries to be 
paid by the cooperative agreement.
6. Collaboration With Treatment Centers
    Describe plans to include local treatment centers in the program.
7. Budget
    A detailed first year's budget for the cooperative agreement with 
projections for the next four additional years.

F. Submission and Deadline

Letter of Intent (LOI)

    On or before June 15, 2002, submit the Letter of Intent to the 
Grants Management Specialist identified in the ``Where to Obtain 
Additional Information'' section of this announcement.

Application

    Submit the original and two copies of PHS 5161-1 (OMB Number 0920-
0428).

[[Page 22436]]

Forms are available in the application kit and at the following 
Internet address: www.cdc.gov/od/pgo/forminfo.htm.
    On or before July 15, 2002, 5:00 pm Eastern Time, submit the 
application to: Technical Information Management Section-PA 02089, 
Procurement and Grants Office, Centers for Disease Control and 
Prevention (CDC), 2920 Brandywine Road, Room 3000, Atlanta, GA 30341-
4146.
    Applications will be considered as meeting the deadline if they are 
received on or before the deadline date. Late applications will be 
returned to the applicant.

G. Evaluation Criteria

    Each application will be evaluated individually against the 
following criteria by an Independent Review Group appointed by CDC.
1. Background and Need (20 points)
    The extent to which the applicant understands the needs, problems, 
objectives and complexities of the program.
2. Objectives (15 points)
    The extent to which the proposed objectives are clearly stated, 
realistic, time-phased, and related to the purpose of the project.
3. Operational Plan (25 points)
    The extent to which the applicant provides a detailed plan of 
proposed activities which are likely to achieve each objective and 
overall program goals. The extent to which the applicant provides a 
reasonable and complete schedule for implementing activities of the 
program.
4. Evaluation Plan (15 points)
    The extent to which the proposed evaluation plan is detailed, 
addresses goals and objectives of the program, and will document the 
program process, effectiveness and outcome. The extent to which a 
feasible plan for reporting evaluation results and using evaluation 
information for programmatic decisions is present.
5. Program Management (20 points)
    a. The extent to which the applicant proposes potentially effective 
collaborations with treatment centers. (10 points)
    b. The extent to which professional personnel proposed to be 
involved in this project are qualified, including evidence of past 
achievements appropriate to this project. (10 points)
6. Measures of Effectiveness (5 points)
    The extent to which the applicant provide Measures of Effectiveness 
that will demonstrate the accomplishment of the various identified 
objectives of the grant. Are the measures objective/quantitative and do 
they adequately measure the intended outcome?
7. Budget (Not scored)
    The extent to which the applicant provides a detailed budget and 
narrative justification consistent with stated objectives and planned 
program activities.

H. Other Requirements

Technical Reporting Requirements

    Provide CDC with original plus two copies of
    1. Semiannual progress reports;
    2. Financial status report, no more than 90 days after the end of 
the budget period; and
    3. Final financial report and performance report, no more than 90 
days after the end of the project period.
    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.
    The following additional requirements are applicable to this 
program. For a complete description of each, see Attachment I of the 
announcement.

AR-10  Smoke-Free Workplace Requirements
AR-11  Healthy People 2010
AR-12  Lobbying Restrictions
AR-15  Proof of Non-Profit Status

I. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under section 301(a) [42 U.S.C. 241(a)] 
and 317 (k)(2) [42 U.S.C. 247b(k)(2)] of the Public Health Service Act, 
as amended. The Catalog of Federal Domestic Assistance number is 
93.283.

J. Where To Obtain Additional Information

    This and other CDC announcements can be found on the CDC home page 
Internet address--http://www.cdc.gov. Click on ``Funding'' then 
``Grants and Cooperative Agreements.''
    If you have questions after reviewing the contents of all the 
documents, business management technical assistance may be obtained 
from: Merlin Williams, Grants Management Specialist, Grants Management 
Branch, Procurement and Grants Office, Centers for Disease Control and 
Prevention, 2920 Brandywine Road, Room 3000, Mailstop K-75, Atlanta, GA 
30341-4146. Telephone number: 770-488-2765. E-mail address: 
[email protected].
    For program technical assistance, contact: Sally Crudder, Acting 
Deputy Chief, Hematologic Diseases Branch, National Center for 
Infectious Diseases, Centers for Disease Control and Prevention, 1600 
Clifton Road, N.E. Mailstop E-64, Atlanta, Georgia 30333. Telephone 
number: 404-371-5270 or 5903. E-mail address: [email protected].

    Dated: April 26, 2002.
Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 02-10834 Filed 5-2-02; 8:45 am]
BILLING CODE 4163-18-P